Source: Υπουργείο Υγείας (CY) Revision Year: 2017 Publisher: Medochemie Ltd., 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
MONOCLOX 250 mg powder for solution for injection or infusion.
MONOCLOX 500 mg powder for solution for injection or infusion.
MONOCLOX 1g powder for solution for injection or infusion.
Pharmaceutical Form |
---|
Powder for solution for injection or infusion. A white or almost white crystalline powder. |
Each vial contains 250mg, 500mg or 1g of cloxacillin dry powder for solution for injection or infusion (as cloxacillin sodium).
For the full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Cloxacillin |
Cloxacillin is a semi-synthetic beta-lactamase resistant penicillin with activity against gram-negative and gram-positive bacteria including beta-lactamase producing staphylococci. Cloxacillin acts by interfering with the formation of new bacterial cell wall by dividing organisms. |
List of Excipients |
---|
None. |
Clear type III glass vials, nominal capacity 8 ml sealed with 20mm rubber stopper, and aluminium caps, labelled, and packed in a card carton.
Boxes of 1, 10, 25, 50 and 100 vials are available.
Not all pack sizes may be marketed.
Medochemie Ltd., 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
MONOCLOX 250 mg powder for solution for injection or infusion: 21024
MONOCLOX 500 mg powder for solution for injection or infusion: 21025
MONOCLOX 1g powder for solution for injection or infusion: 21026
22.08.2011 / 23/01/2017
Drug | Countries | |
---|---|---|
MONOCLOX | Cyprus, Hong Kong, Croatia |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.